{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:39:05Z","timestamp":1790908745542,"version":"4.1.0"},"reference-count":33,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kyowa Kirin International"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Tumor-induced osteomalacia (TIO) is an ultra-rare, paraneoplastic syndrome caused by tumors that secrete fibroblast growth factor 23 (FGF23). Initial signs and musculoskeletal symptoms can be nonspecific and unrecognized, leading to long delays in diagnosis and treatment, and resulting in severe and progressive disability in patients with TIO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review aimed to identify published evidence on healthcare resource use in TIO to better understand the burden of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence acquisition<\/jats:title>\n                    <jats:p>A targeted literature review was conducted to identify publications reporting on disease characteristics and healthcare resource use associated with TIO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence synthesis<\/jats:title>\n                    <jats:p>In total, 414 publications were included in the review, of which 376 were case reports. From the case reports, data on 621 patients were extracted. These patients had a mean (SD) age of 46.3 (15.8) years; 57.6% were male. Mean time from first symptoms to diagnosis of TIO was 4.6 (4.7) years and, in cases where imaging tests were reported, patients underwent a mean of 4.1 (2.7) procedures. Tumor resection was attempted in 81.0% of patients and successful in 67.0%. Fracture was reported in 49.3% of patients. Results from association analyses demonstrated that longer time to diagnosis was associated with poorer tumor resection outcomes and a higher probability of tumor recurrence. Unfavorable tumor resection outcomes were associated with greater use of pharmacologic treatment and a greater likelihood of orthopedic surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TIO is associated with a substantial healthcare resource burden. Improvements in the diagnostic process could lead to better management of TIO, thereby benefiting patients and reducing that burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae431","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T18:44:25Z","timestamp":1718909065000},"page":"102-113","source":"Crossref","is-referenced-by-count":7,"title":["Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review"],"prefix":"10.1210","volume":"110","author":[{"given":"Suzanne M","family":"Jan de Beur","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia , Charlottesville, VA 22903 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M","family":"Dahir","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center , Nashville, TN 37232 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A","family":"Imel","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Pediatrics (Endocrinology), Indiana University School of Medicine , Indianapolis, IN 46202-5111 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Zanchetta","sequence":"additional","affiliation":[{"name":"Instituto de Investigaciones Metab\u00f3licas, Universidad del Salvador , Buenos Aires, ZC 1012 ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Outcomes Research, Kyowa Kirin International , Marlow, Buckinghamshire, SL7 1HZ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Outcomes Research, Kyowa Kirin North America , Bedminster, NJ 07921 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-0837","authenticated-orcid":false,"given":"Neil","family":"Webb","sequence":"additional","affiliation":[{"name":"Systematic Review Department, Source Health Economics , Oxford, OX2 7BY ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Crowe","sequence":"additional","affiliation":[{"name":"Systematic Review Department, Source Health Economics , Oxford, OX2 7BY ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3938-0920","authenticated-orcid":false,"given":"Ben","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Outcomes Research, Kyowa Kirin International , Marlow, Buckinghamshire, SL7 1HZ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-6768","authenticated-orcid":false,"given":"Thomas O","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics (Endocrinology) and Orthopaedics and Rehabilitation, Yale School of Medicine , New Haven, CT 06520-8064 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"issue":"1","key":"2024121723512357900_dgae431-B1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced osteomalacia","volume":"108","author":"Florenzano","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"2024121723512357900_dgae431-B2","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2024121723512357900_dgae431-B3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"Jan de Beur","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024121723512357900_dgae431-B4","doi-asserted-by":"crossref","first-page":"e10436","DOI":"10.1002\/jbm4.10436","article-title":"Burden of disease in patients with tumor-induced osteomalacia","volume":"5","author":"Jerkovich","year":"2020","journal-title":"JBMR Plus"},{"issue":"9","key":"2024121723512357900_dgae431-B5","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00198-022-06432-9","article-title":"A literature review to understand the burden of disease in people living with tumour-induced osteomalacia","volume":"33","author":"Minisola","year":"2022","journal-title":"Osteoporos Int"},{"issue":"2","key":"2024121723512357900_dgae431-B6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00223-021-00843-2","article-title":"Epidemiology of tumor-induced osteomalacia in Denmark","volume":"109","author":"Abrahamsen","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2024121723512357900_dgae431-B7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00223-023-01148-2","article-title":"Epidemiology of tumor-induced osteomalacia in Germany based on real world data","volume":"113","author":"May","year":"2023","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2024121723512357900_dgae431-B8","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024121723512357900_dgae431-B9","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024121723512357900_dgae431-B10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.afos.2018.12.001","article-title":"Tumor-induced osteomalacia","volume":"4","author":"Yin","year":"2018","journal-title":"Osteoporos Sarcopenia"},{"issue":"3","key":"2024121723512357900_dgae431-B11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13593","article-title":"Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia","volume":"293","author":"Jan de Beur","year":"2023","journal-title":"J Intern Med"},{"issue":"9","key":"2024121723512357900_dgae431-B12","doi-asserted-by":"crossref","first-page":"bvab099","DOI":"10.1210\/jendso\/bvab099","article-title":"Diagnosis and management of tumor-induced osteomalacia: perspectives from clinical experience","volume":"5","author":"Dahir","year":"2021","journal-title":"J Endocr Soc"},{"issue":"12","key":"2024121723512357900_dgae431-B13","doi-asserted-by":"crossref","first-page":"bvaa151","DOI":"10.1210\/jendso\/bvaa151","article-title":"X-linked hypophosphatemia: a new era in management","volume":"4","author":"Dahir","year":"2020","journal-title":"J Endocr Soc"},{"key":"2024121723512357900_dgae431-B14","author":"BioSpace"},{"key":"2024121723512357900_dgae431-B15","author":"EMA"},{"key":"2024121723512357900_dgae431-B16","author":"Kyowa Kirin"},{"issue":"6","key":"2024121723512357900_dgae431-B17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40265-018-0905-7","article-title":"Burosumab: first global approval","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"key":"2024121723512357900_dgae431-B18","first-page":"307","article-title":"Healthcare resource utilization associated with tumor-induced osteomalacia: review of patient histories prior to entry in clinical trial UX023T-CL201 [abstract]","volume":"75","author":"Jan de Beur","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024121723512357900_dgae431-B19","doi-asserted-by":"crossref","unstructured":"Jan de Beur SM, Dahir K, Imel E, et al \u00a02024. Supplementary material to \u201cHealthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review\u201d. Dryad Digital Repository. Date of deposit 20 March 2024. 10.5061\/dryad.stqjq2c9j","DOI":"10.1210\/clinem\/dgae431"},{"issue":"8","key":"2024121723512357900_dgae431-B20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024121723512357900_dgae431-B21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"issue":"4","key":"2024121723512357900_dgae431-B22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00223-022-01005-8","article-title":"Tumor-induced osteomalacia: a systematic clinical review of 895 cases","volume":"111","author":"Bosman","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"8","key":"2024121723512357900_dgae431-B23","doi-asserted-by":"crossref","first-page":"e3428","DOI":"10.1210\/clinem\/dgac253","article-title":"Tumor-induced osteomalacia: a systematic review and individual patient's data analysis","volume":"107","author":"Rendina","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024121723512357900_dgae431-B24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9343(84)90112-8","article-title":"Oncogenous osteomalacia: review of the world literature of 42 cases and report of two new cases","volume":"77","author":"Ryan","year":"1984","journal-title":"Am J Med"},{"issue":"9","key":"2024121723512357900_dgae431-B25","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2024121723512357900_dgae431-B26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1530\/EC-19-0341","article-title":"Tumor induced osteomalacia in head and neck region: single center experience and systematic review","volume":"8","author":"Shah","year":"2019","journal-title":"Endocr Connect"},{"issue":"2","key":"2024121723512357900_dgae431-B27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing burosumab efficacy and safety in patients with tumor-induced osteomalacia","volume":"36","author":"Imanishi","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024121723512357900_dgae431-B28","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jbmr.4900","article-title":"Burosumab improves patient-reported outcomes in adults with tumor-induced osteomalacia: mixed-methods analysis","volume":"38","author":"Jan de Beur","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024121723512357900_dgae431-B29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-022-02299-5","article-title":"The national economic burden of rare disease in the United States in 2019","volume":"17","author":"Yang","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2024121723512357900_dgae431-B30","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae183","article-title":"A retrospective cohort of tumor-induced osteomalacia and case series of malignant disease","author":"Hoong","year":"20, 2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024121723512357900_dgae431-B31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1530\/EC-18-0552","article-title":"Tumor-induced osteomalacia: experience from three tertiary care centers in India","volume":"8","author":"Pal","year":"2019","journal-title":"Endocr Connect"},{"issue":"12","key":"2024121723512357900_dgae431-B32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/RLU.0000000000002290","article-title":"Increased activity due to fractures does not significantly affect the accuracy of 68Ga-DOTATATE PET\/CT in the detection of culprit tumor in the evaluation of tumor-induced osteomalacia","volume":"43","author":"Ding","year":"2018","journal-title":"Clin Nucl Med"},{"issue":"2","key":"2024121723512357900_dgae431-B33","doi-asserted-by":"crossref","first-page":"bvac181","DOI":"10.1210\/jendso\/bvac181","article-title":"Utility of multimodality approach including systemic FGF23 venous sampling in localizing phosphaturic mesenchymal tumors","volume":"7","author":"Kato","year":"2022","journal-title":"J Endocr Soc"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae431\/58484917\/dgae431.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/1\/102\/61213457\/dgae431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/1\/102\/61213457\/dgae431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T18:52:14Z","timestamp":1734461534000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/1\/102\/7698011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,6,24]]},"published-print":{"date-parts":[[2024,12,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae431","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,6,24]]}}}